Literature DB >> 2216229

Single dose of nifedipine in normotensive pregnancy: nifedipine concentrations, hemodynamic responses, and uterine and fetal flow velocity waveforms.

J P Pirhonen1, R U Erkkola, U U Ekblad, L Nyman.   

Abstract

The short-term effect of 20 mg of oral nifedipine on maternal and fetal hemodynamics was investigated in ten healthy, normotensive women at 38 weeks' gestation admitted to the hospital for elective cesarean delivery. Within 1 hour after nifedipine administration, mean arterial pressure had decreased by 10% and a slight increase was observed in maternal heart rate. A statistically significant (P less than .01) decrease in the systolic-diastolic ratio was found in the flow velocity waveform from the uterine artery, but no change was seen in that from the arcuate artery. No changes were observed in the fetal heart rate pattern or in umbilical or thoracic aortic flow velocity waveforms. Nifedipine concentrations in the mother had no correlation with maternal or fetal hemodynamic responses. At delivery 2.5 hours after nifedipine ingestion, the umbilical venous-maternal ratio of nifedipine concentrations was 0.76.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2216229     DOI: 10.1097/00006250-199011000-00016

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic.

Authors:  David M Haas; Sara K Quinney; Jayanti M Clay; Jamie L Renbarger; Mary F Hebert; Shannon Clark; Jason G Umans; Steve N Caritis
Journal:  Am J Perinatol       Date:  2012-08-08       Impact factor: 1.862

Review 2.  The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions.

Authors:  Ian R Mulrenin; Julian E Garcia; Muluneh M Fashe; Matthew Shane Loop; Melissa A Daubert; Rachel Peragallo Urrutia; Craig R Lee
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-11       Impact factor: 4.481

3.  Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis.

Authors:  Tijn M S van Winden; Tobias A J Nijman; C Emily Kleinrouweler; Raed Salim; Maryam Kashanian; Wafa R Al-Omari; Eva Pajkrt; Ben W Mol; Martijn A Oudijk; Carolien Roos
Journal:  BMC Pregnancy Childbirth       Date:  2022-07-15       Impact factor: 3.105

4.  Management of preterm labor: atosiban or nifedipine?

Authors:  Roel de Heus; Eduard J H Mulder; Gerard H A Visser
Journal:  Int J Womens Health       Date:  2010-08-09

5.  Nifedipine compared to magnesium sulfate for treating preterm labor: A randomized clinical trial.

Authors:  Roshan Nikbakht; Mahin Taheri Moghadam; Homa Ghane'ee
Journal:  Iran J Reprod Med       Date:  2014-02

Review 6.  Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.

Authors:  Divya Murthy; Kuldeep S Attri; Pankaj K Singh
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

Review 7.  Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.

Authors:  Dylan van de Vusse; Paola Mian; Sam Schoenmakers; Robert B Flint; Willy Visser; Karel Allegaert; Jorie Versmissen
Journal:  Eur J Clin Pharmacol       Date:  2022-09-15       Impact factor: 3.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.